Protein 169 increases 80S monosomes and decreases polysomes. by Pavla Strnadova (383776)

Binding mode of clavulanic acid with active site residues of SHV S130G mutant at different time intervals (a) binding of ca at 0 ns (b) binding of ca at 2 ns (c) binding of ca at 5... by Mohd Hassan Baig (441304)

Mutations in p38 MAP kinase components and the mucolipin ortholog CUP-5 suppress the decrease in abundance of EVA-1 in <i>madd-3</i> mutants. by Serena A. D’Souza (2635801)

Quantification of <i>ATP5B</i> mRNA and β-F1-ATPase protein expression shows decreased protein translation in obesity. by Lee Tran (2106961)

Mutations in p38 MAP kinase components and the mucolipin ortholog CUP-5 suppress the decrease in abundance of RAB-7 in <i>madd-3</i> mutants. by Serena A. D’Souza (2635801)

Fig 5 - by Marian Adan (16641634)

Laser scanning confocal microscopy images (a) and quantification (b) of the relative levels of 5-methylcytosine (5mc) and 5-hydroxymethylcytosine (5hmc) in early embryos at the pro... by Shuang Liang (211832)

Subjects:

Intracellular ROS decrease mediated by TAT-fused protein delivery. by Cecilia L. Balaban (4424212)

scSOX9 induced increased expression of SOX5, SOX9 and collagen II but decreased expression of collagen I and X. by Xiaowei Zhang (6505)

Overexpression of miR-219-5p in glioma cell lines decreased proliferation, anchorage independent growth and migration of glioma cells. by Soumya Alige Mahabala Rao (413479)

Scenario (6): Parameter variation (50% decrease)—With 5 N.m load applied at t = 0.3s. by Djaloul Karboua (16510091)

“…<p>Scenario (6): Parameter variation (50% decrease)—With 5 N.m load applied at t = 0.3s.</p>…”

Glu58 and Arg87 minimal distance decreases upon activation. by Maxime Louet (150102)

Western blot analysis on Huh-7 cells following incubation with decreasing concentrations of wild-type PCSK9 (500 nM, 50 nM and 5 nM) or gain-of-function PCSK9 D374Y mutant (20 nM, 2 nM and 0.2 nM) and 200 nM of alirocumab (monoclonal antibody to PCSK9) or isotype control monoclonal antibody for 6 hours. by Aarti Ramanathan (2626780)

Resveratrol decreased tumor latency in <i>Sirt1^Y/+</i> mice. by Katherine V. Clark-Knowles (368164)

<i>In vivo</i> epigenetic therapy sensitize CRC cell line xenografts to decrease tumor burden. by Anup Sharma (253963)

M344 decreases orthotopic pancreatic tumor growth when used as a treatment alone or in combination with gemcitabine. by Shelby M. Knoche (13833807)

The Karolinska Sleepiness Scale (KSS) is a 9-point Likert scale, ranging from “extremely 1 = alert” to “9 = extremely sleepy–fighting sleep” [44]. by Marcel F. Hinss (14675457)

Compared to vorinostat, M344 decreases pancreatic cancer cell proliferation more effectively for a longer duration. by Shelby M. Knoche (13833807)

PKCε activation induces aggrecan gene expression, decreases ADAMTS5, and detection of ADAMTS-5-depended cleavage of ECM aggrecan through upregulation of hsa-miR-377 expression. by Emmanouella Tsirimonaki (490707)

“…<p>(<b>A</b>) RT-PCR detected the relative expression of ACAN, MKI67, ADAMTS5 after treatment of NP cells with 1 μM ψεRACK (or vehicle) for indicated times and revealed that time-dependent activation of PKCε significantly increased the mRNA expression for aggrecan, while in an opposing manner decreased ADAMTS5; mRNA levels of the proliferation marker Ki67 became barely detectable after 8 hours of PKCε activation. …”

Exogenous hαS decreases neuronal activity and synchronicity of neuronal action potential firing pattern. by G. C. Hassink (4993532)